Neurocognitive functioning in patients with first-episode schizophrenia : results of a prospective 5-year follow-up study
- PMID: 17031490
- DOI: 10.1007/s00406-006-0667-1
Neurocognitive functioning in patients with first-episode schizophrenia : results of a prospective 5-year follow-up study
Abstract
To assess the course of neuropsychological (NP) impairment in schizophrenia, 71 patients with first episode (FE) schizophrenia and 71 healthy controls were given a comprehensive battery of NP tests at index assessment, after a 2-year and after a 5-year follow-up period. By means of the z-score standardization, summary scores for verbal intelligence (VBI), spatial organisation (SPT), verbal fluency (VBF), Verbal learning (VBL), semantic memory (SEM), visual memory (VIM), delay/retention rate (DEL), short-term memory (STM), visuomotor processing and attention (VSM) and abstraction/flexibility (ABS) were constructed. FE schizophrenia patients showed a worse performance compared to controls in all areas investigated, most pronounced in VSM, SEM and VBL. In the majority of cognitive domains, an improvement was found over the 5-year follow-up period without differences between the two groups. However, in VBF patients slightly deteriorated whilst controls improved and in memory functions patients improved less compared to controls. When controlling for relevant confounders, neither conventional nor atypical neuroleptics showed a deleterious influence on NP performance, except on VBF. Our data suggest that NP impairment is already present at the onset of the illness and remains stable over the early course of schizophrenia.
Similar articles
-
A prospective 2-year follow-up study of neurocognitive functioning in patients with first-episode schizophrenia.Eur Arch Psychiatry Clin Neurosci. 2002 Dec;252(6):262-7. doi: 10.1007/s00406-002-0391-4. Eur Arch Psychiatry Clin Neurosci. 2002. PMID: 12563534
-
Neurocognitive functioning in patients with first-episode schizophrenia 1 year from onset in comparison with patients 5 years from onset.Int J Psychiatry Clin Pract. 2014 Jan;18(1):63-9. doi: 10.3109/13651501.2013.845220. Epub 2013 Oct 28. Int J Psychiatry Clin Pract. 2014. PMID: 24047425
-
Cognitive functioning in the early course of first-episode schizophrenia spectrum disorders: timing and patterns.Eur Arch Psychiatry Clin Neurosci. 2006 Sep;256(6):364-71. doi: 10.1007/s00406-006-0646-6. Epub 2006 Jun 20. Eur Arch Psychiatry Clin Neurosci. 2006. PMID: 16788772
-
Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.Clin Ther. 2008 Sep;30(9):1565-89. doi: 10.1016/j.clinthera.2008.09.014. Clin Ther. 2008. PMID: 18840365 Review.
-
Neurocognition in youth and young adults under age 30 at familial risk for schizophrenia: a quantitative and qualitative review.Cogn Neuropsychiatry. 2013;18(1-2):44-82. doi: 10.1080/13546805.2012.676309. Epub 2012 Sep 21. Cogn Neuropsychiatry. 2013. PMID: 22998599 Free PMC article. Review.
Cited by
-
Level and pattern of neuropsychological functioning in early-onset psychoses.Eur Child Adolesc Psychiatry. 2011 Dec;20(11-12):551-60. doi: 10.1007/s00787-011-0219-8. Epub 2011 Oct 12. Eur Child Adolesc Psychiatry. 2011. PMID: 21989901
-
Current source density (CSD) old/new effects during recognition memory for words and faces in schizophrenia and in healthy adults.Int J Psychophysiol. 2010 Feb;75(2):194-210. doi: 10.1016/j.ijpsycho.2009.12.001. Epub 2009 Dec 6. Int J Psychophysiol. 2010. PMID: 19995583 Free PMC article.
-
Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptoms.Eur Arch Psychiatry Clin Neurosci. 2007 Sep;257(6):360-70. doi: 10.1007/s00406-007-0739-x. Epub 2007 Jul 14. Eur Arch Psychiatry Clin Neurosci. 2007. PMID: 17629731 Clinical Trial.
-
Domain-specific cognitive course in schizophrenia: Group- and individual-level changes over 10 years.Schizophr Res Cogn. 2022 Jun 22;30:100263. doi: 10.1016/j.scog.2022.100263. eCollection 2022 Dec. Schizophr Res Cogn. 2022. PMID: 35783460 Free PMC article.
-
Associations of SNAP-25 polymorphisms with cognitive dysfunctions in Caucasian patients with schizophrenia during a brief trail of treatment with atypical antipsychotics.Eur Arch Psychiatry Clin Neurosci. 2008 Sep;258(6):335-44. doi: 10.1007/s00406-007-0800-9. Epub 2008 Mar 17. Eur Arch Psychiatry Clin Neurosci. 2008. PMID: 18347838 Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous